Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1601 - 1625 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Blinatumomab (Blincyto) for Ph- ALL	pcodr_profund_blinatumomab_blincyto_all.pdf blinatumomab_blincyto_all_fn_rec.pdf blinatumomab_blincyto_all_fn_cgr.pdf blinatumomab_blincyto_all_fn_egr.pdf pcodr_blinatumomab_blincyto_all_in_rec.pdf blinatumomab_blincyto_all_pagfdk.pdf blinatumomab_blincyto_all_fdk_amgen.pdf blinatumomab_blincyto_all_ptfdk_ccsn.pdf blinatumomab_blincyto_all_coi_ccsn.pdf	Apr 18, 2016	Reimbursement Review	Complete	PC0064-000
Opdivo for Metastatic Melanoma - Details	pcodr_provfund_nivolumab_opdivo_metmela.pdf nivolumab_opdivo_mm_fn_rec.pdf nivolumab_opdivo_mm_fn_cgr.pdf nivolumab_opdivo_mm_fn_egr.pdf pcodr_nivolumab_opdivo_metmela_in_rec.pdf nivolumab_opdivo_mm_pagfdk.pdf nivolumab_opdivo_mm_fdk_bms.pdf nivolumab_opdivo_mm_ptfdk_mnc.pdf nivolumab_opdivo_mm_coi_mnc.pdf	Apr 18, 2016	Reimbursement Review	Complete	PC0063-000
perindopril arginine / amlodipine	cdr_SR0490_Viacoram.pdf SR0490_complete_Viacoram-Oct-28-16.pdf SR0490_Viacoram_CL_Report.pdf SR0490_Viacoram_PE_Report.pdf	Apr 4, 2016	Reimbursement Review	Complete	SR0490-000
Guidance Document for the Costing of Health Care Resources in the Canadian Setting: Second Edition		Mar 30, 2016	Health Technology Review		MH0002-CP0009
Empagliflozin	cdr_SR0488_Jardiance.pdf SR0488_complete_Jardiance-Oct-28-16.pdf SR0488_Jardiance_CL_Report.pdf SR0488_Jardiance_PE_Report.pdf SR0488_Jardiance_PI_Submissions.pdf	Mar 30, 2016	Reimbursement Review	Complete	SR0488-000
Sofosbuvir/ velpatasvir	cdr_SR0486_TBC.pdf SR0486_complete_Epclusa-Oct-28-16.pdf SR0486_Epclusa_CL_Report.pdf SR0486_Epclusa_PE_Report.pdf SR0486_Epclusa_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0486-000
Vedolizumab	cdr_SR0487_Entyvio.pdf SR0487_complete_Entyvio-Oct-31-16.pdf SR0487_Entyvio_CL_Report.pdf SR0487_Entyvio_PE_Report.pdf SR0487_Entyvio_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0487-000
Jakavi for Polycythemia Vera - Details	pcodr_profund_ruxolitinib_jakavi_pv.pdf pcodr_ruxolitinib_jakavi_pv_fn_rec.pdf pcodr_ruxolitinib_jakavi_pv_fn_cgr.pdf pcodr_ruxolitinib_jakavi_pv_fn_egr.pdf pcodr_ruxolitinib_jakavi_pv_in_rec.pdf pcodr_ruxolitinib_jakavi_pv_pagfdk.pdf pcodr_ruxolitinib_jakavi_pv_fdk_novartis.pdf pcodr_ruxolitinib_jakavi_pv_ptfdk_mpn.pdf pcodr_ruxolitinib_jakavi_pv_coi_mpn.pdf	Mar 18, 2016	Reimbursement Review	Complete	PC0065-000
Brivaracetam	cdr_SR0484_Brivlera.pdf SR0484_Brivlera_CL_Report.pdf SR0484_Brivlera_PE_Report.pdf sr0484_complete_brivlera_jan-27-17.pdf	Mar 17, 2016	Reimbursement Review	Complete	SR0484-000
Infliximab	cdr_SE0483_Inflectra.pdf SE0483_IBD_Inflectra-Oct-28-16.pdf SE0483_Inflectra_PI_Submission_Consolidated.pdf SE0483_Inflectra_SEB_Report.pdf	Mar 11, 2016	Reimbursement Review	Complete	SE0483-000
Etanercept	cdr_SE0485_TBC.pdf SE0485_complete_Brenzys-Oct-27-16.pdf se0485_brenzys_pi.pdf se0485_brenzys_seb_report.pdf	Mar 9, 2016	Reimbursement Review	Complete	SE0485-000
Ixekizumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0481_TBC.pdf SR0481_complete_Taltz-oct-27-16.pdf SR0481_Taltz_PI_Submissions.pdf SR0481_Taltz_CL_Report_e.pdf SR0481_Taltz_PE_Report_e.pdf	Feb 17, 2016	Reimbursement Review	Complete	SR0481-000
Selexipag	cdr_SR0482_Uptravi.pdf SR0482_complete_Uptravi-Oct-28-16.pdf SR0482_Uptravi_PI_Submissions.pdf SR0482_Uptravi_CL_Report_e.pdf SR0482_Uptravi_PE_Report.pdf	Feb 16, 2016	Reimbursement Review	Complete	SR0482-000
Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives	ES0300_Rare_Disease_Drugs_e.pdf	Feb 11, 2016	Health Technology Review		ES0300-000
Emtricitabine/tenofovir disoproxil fumarate	cdr_SR0479_Truvada.pdf SR0479_complete_Truvada_Aug-26-16.pdf SR0479_Truvada_CL_Report.pdf SR0479_Truvada_PE_Report.pdf SR0479_Truvada_PI_Submissions.pdf	Feb 4, 2016	Reimbursement Review	Complete	SR0479-000
Apremilast	cdr_SR0478_Otezla_Resub.pdf SR0478_complete_Otezla-Oct-28-16.pdf SR0478_Otezla_PI_Submissions.pdf SR0478_Otezla_CL_Report_e.pdf SR0478_Otezla_PE_Report_e.pdf	Jan 29, 2016	Reimbursement Review	Complete	SR0478-000
Secukinumab	cdr_SR0475_Cosentyx_AS.pdf SR0475_complete_Cosentyx_AS_Aug-25-16.pdf SR0475_CosentyxAS_CL_Report.pdf SR0475_CosentyxAS_PE_Report.pdf SR0475_CosentyxAS_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0475-000
Secukinumab	cdr_SR0476_Cosentyx_PsA.pdf SR0476_complete_Cosentyx_PsA_Aug-25-16.pdf SR0476_CosentyxPsA_CL_Report.pdf SR0476_CosentyxPsA_PE_Report.pdf SR0476_CosentyxPsA_PI_Submissions.pdf	Jan 21, 2016	Reimbursement Review	Complete	SR0476-000
Mifepristone and misoprostol	cdr_SR0473_Mifegymiso.pdf	Jan 18, 2016	Reimbursement Review	Withdrawn	SR0473 -000
ombitasvir/paritaprevir/ritonavir and dasabuvir	cdr_SF0466_Holkira_Pak.pdf SF0466_complete_Holkira_Pak_May-25-16.pdf SF0466_HolkiraPak_RfA_Review_Report.pdf SF0466_HolkiraPak_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0466-000
daclatasvir	cdr_SF0467_Daklinza.pdf SF0467_complete_Daklinza_May_25-16.pdf SF0467_Daklinza_RfA_Review_Report.pdf SF0467_Daklinza_RfA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0467-000
sofosbuvir	cdr_SF0464_Sovaldi.pdf SF0464_complete_Sovaldi-May_19_16.pdf SF0464_Sovaldi_RfA_Review_Report.pdf SF0464_Sovaldi_RFA_PI_Submissions.pdf	Jan 6, 2016	Reimbursement Review	Complete	SF0464-000
Sapropterin dihydrochloride	cdr_SR0472_Kuvan.pdf SR0472_complete_Kuvan-Oct-28-16.pdf SR0472_Kuvan_PI_Submissions.pdf SR0472_Kuvan_CL_Report_e.pdf SR0472_Kuvan_PE_Report_e.pdf	Jan 4, 2016	Reimbursement Review	Complete	SR0472-000
Vectibix for mCRC – Details	pcodr_provfund_panitumumab_vectibix_mcrc.pdf pcodr_panitumumab_vectibix_mcrc_fn_rec.pdf pcodr_panitumumab_vectibix_mcrc_fn_cgr.pdf pcodr_panitumumab_vectibix_mcrc_fn_egr.pdf pcodr_panitumumab_vectibix_mcrc_in_rec.pdf pcodr_panitumumab_vectibix_mcrc_pagfdk.pdf pcodr_panitumumab_vectibix_mcrc_fdk_amgen.pdf pcodr_panitumumab_vectibix_mcrc_coi_ccac.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0060-000
Revlimid for Newly Diagnosed MM – Details	pcodr_provfund_lenalidomide_revlimid_nd-mm.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_cgr.pdf pcodr_lenalidomide_revlimid_nd-mm_fn_egr.pdf pcodr_lenalidomide_revlimid_mm_in_rec.pdf pcodr_lenalidomide_revlimid_nd-mm_pagfdk.pdf pcodr_lenalidomide_revlimid_nd-mm_fdk_celgene.pdf pcodr_lenalidomide_revlimid_nd-mm_coi_mc.pdf	Dec 18, 2015	Reimbursement Review	Complete	PC0061-000